After Hours
$
247.28
Change
-1.11 -0.45%
Volume
Volume 515,807
Aug 12, 2022, 7:30 p.m.
Quotes are delayed by 20 min
Previous close
$ 248.35
$ 248.39
Change
+0.04 +0.02%
Day low
Day high
$246.30
$249.85

52 week low
52 week high
$198.64
$258.45

Market cap
$132.69B
Average volume
3.01M
P/E ratio
21.05
Rev. per Employee
$1.09M
EPS
11.80
Dividend
1.94
Div yield
3.12%
Ex dividend date
8/17/22
MarketWatch News on AMGN
-
Amgen Acquires Drugmaker ChemoCentryx for $3.7 Billion
- Karishma Vanjani
-
The Bull Market in Biotech Is Still Going Strong
- Josh Nathan-Kazis
-
Amgen to pay $52 per Chemocentryx share in deal expected to close in Q4
- Ciara Linnane
-
Amgen to acquire Chemocentryx for $4 bln in cash
- Ciara Linnane
-
AMD, PayPal, Starbucks, Uber, Paramount, and Other Stocks to Watch This Week
- Nicholas Jasinski
-
Merck, Salesforce Inc. share losses contribute to Dow's 100-point drop
- MarketWatch Automation
-
Dow up 63 points on gains for shares of UnitedHealth, Amgen Inc.
- MarketWatch Automation
-
Stock Futures Creep Higher After Release of Fed Minutes
- William McCormack
-
The Days of Big Pharma Are Over. What Big Biotech Means for Investors.
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
-
Analysts Raise Ratings on Teva Stock on Ajovy’s FDA Approval
- MarketRealist.com
-
Analysts’ Latest Recommendations on Mylan
- MarketRealist.com
-
Analysts Raise Their 12-Month Target Price on Teva Pharmaceutical
- MarketRealist.com
Other News on AMGN
-
Top 5 2nd Quarter Trades of COMMERCE BANK
- GuruFocus.com
-
Drug-Price Rules for Seniors Change With Bill’s Passage
- Joseph Walker
-
Top 5 2nd Quarter Trades of GREAT WEST LIFE ASSURANCE CO /CAN/
- GuruFocus.com
-
SCHD Vs. VOO: Which ETF Is The Better Buy?
- Seeking Alpha
-
Amgen under fire from Sen. Wyden over tax practices - Reuters
- Seeking Alpha
-
Upcoming Ex-Dividend Dates: July 15-28, 2022
- Seeking Alpha
-
The Highest Quality Dividend Growth Stocks In 2022
- Seeking Alpha
-
Eli Lilly Hits Some Bumps in the Road
- GuruFocus.com
-
Top 5 2nd Quarter Trades of Hikari Tsushin, Inc.
- GuruFocus.com
-
- Seeking Alpha
-
Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics
- Jonathan D. Rockoff
- Loading more headlines...
Earnings Announcement
Press Releases on AMGN
-
- Stock Traders Daily
-
AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022
- PR Newswire - PRF
-
Leukemia Therapeutics Market Growth by Forthcoming Developments 2028
- AmericaNewsHour
-
SHAREHOLDER ALERT: Weiss Law Investigates ChemoCentryx, Inc
- PR Newswire - PRF
-
AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
- PR Newswire - PRF
-
Daily Dividend Report: UPS,AMGN,ADP,KRO,SLF
- MarketNewsVideo.com
-
AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
- PR Newswire - PRF
-
- Stock Traders Daily
-
AMGEN APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS
- PR Newswire - PRF
-
AMGEN ANNOUNCES 2022 THIRD QUARTER DIVIDEND
- PR Newswire - PRF
-
AMGEN TO WEBCAST INVESTOR MEETING AT WCLC 2022
- PR Newswire - PRF
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
-
AMGEN ANNOUNCES WEBCAST OF 2022 SECOND QUARTER FINANCIAL RESULTS
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com